Stefana Impera

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial

Esther Natalie Olíva, Caterina Alati, Valeria Santini et al. · The Lancet Haematology · 2017 · 162 citations · Full text

Medicine, Hematology, Pharmacotherapy +8

Differences among young adults, adults and elderly chronic myeloid leukemia patients

Fabio Castagnetti, Gabriele Gugliotta, Michele Baccarani et al. · Annals of Oncology · 2014 · 99 citations · Full text

Medicine, Geriatric Medicine, Oncology +10

Quality of life in elderly patients with acute myeloid leukemia: patients may be more accurate than physicians

Esther Natalie Olíva, Francesco Nobile, G. Alimena et al. · Haematologica · 2011 · 74 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Quality of life and physicians' perception in myelodysplastic syndromes.

Carlo Finelli, Valeria Santini, Antonella Poloni et al. · PubMed · 2012 · 51 citations · Full text

Medicine, Hematology, Internal Medicine +12

Darbepoetin alfa for the treatment of anemia associated with myelodysplastic syndromes: efficacy and quality of life

Esther Natalie Olíva, Francesco Nobile, Giuliana Alimena et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 41 citations

Medicine, Hematology, Pharmacology +13